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Varicella-Zoster Virus Is Strongly Associated with Atypical Necrotizing
Herpetic Retinopathies
J. Garweg and M. Biihnke 	 From the Department of Ophthalmology, University of Bern,
Inselspital, Bern, Switzerland
Aqueous humor samples from nine patients with atypical necrotizing retinopathies of suspected
viral origin, six with acute retinal necrosis syndrome (ARN), and 17 with active cytomegalovirus
(CMV) retinitis underwent amplification for viral DNA of herpes simplex virus type 1 (HSV-1),
varicella-zoster virus (VZV), and human CMV. VZV DNA was detected in seven of the nine aqueous
humor samples from patients with atypical necrotizing retinopathies of suspected viral origin and
in four of the six samples from individuals with ARN; of the two other samples from patients with
ARNS, no viral DNA was found in one, and both CMV DNA and HSV-1 DNA, but not VZV DNA,
were detected in one (this patient presented with bilateral ARNS 2 months after being successfully
treated for CMV retinitis). Thus, VZV is likely to be the main pathogen of atypical necrotizing
herpetic retinopathies. DNA amplification may be used to establish an early, sensitive, and reliable
diagnosis of any form of necrotizing retinopathy in 80% of cases, irrespective of viral etiology.
Acute necrotizing retinitis has long been recognized as an
associated complication of several disorders in which symp-
toms of an immunocompromised state, such as Hodgkin's
disease, are manifested [1-3]. However, Urayama et al. [4]
were the first to describe this condition in immunocompetent,
otherwise healthy individuals, and they termed it acute retinal
necrosis syndrome (ARN). The well-defined clinical picture
includes acute iridocyclitis, vitritis, visual deterioration, necro-
tizing retinitis, occlusive retinal vasculitis, and eventually rheg-
matogenous detachment of the atrophic retina.
In unilaterally diagnosed cases of acute necrotizing retinitis,
subsequent involvement of the other eye occurs within 1 year
in 30% [5] to 70% [6] of cases, but late involvement after a
lapse of up to 26 years has been reported [7]; risk to the second
eye can be reduced by about 80% [6] if virustatic therapy with
acyclovir is administered for months. Patients may have a
history of previous systemic disease, such as herpes simplex
or zoster dermatitis, but by no means is this a matter of course
[8, 9]. In immunocompromised patients, lesions of suspected
viral origin do not always bear the hallmarks of well-character-
ized clinical syndromes, such as ARN or cytomegalovirus
(CMV) retinopathy, and these lesions have been categorized
together under the designation "necrotizing herpetic retinopa-
thies" [10].
After an individual has become infected, it is reasonable
to expect that viral particles will remain predominantly
cell-associated. For this reason, cultures of samples from the
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virtually cell-free aqueous and vitreous compartments are nega-
tive; therefore, such means cannot be used to establish viral
etiology [9, 11, 12]. However, analysis of paired aqueous and
serum samples for the existence of specific antibodies has led
to successful diagnoses in 65% of cases [13-15]; if this proce-
dure is carried out on a sequential basis, 72%-86% of cases
may be successfully diagnosed [16].
Of course, more invasive measures, such as vitreoretinal
biopsy, may also be implemented to confirm viral etiology
[17], but these measures are indicated only in cases where the
disease progresses despite therapy and implicates both eyes;
however, a specific infrastructure is required for their execu-
tion, and this substructure is not always available [18]. By
using DNA detection methods, the infection may be diagnosed
in <48 hours after the onset of clinical symptoms [19], and this
result can then be later corroborated by sequential serological
analysis.
In this prospective study, aqueous humor samples from pa-
tients with recently diagnosed atypical necrotizing retinopathies
of unknown origin, patients with ARN, and patients with CMV
retinitis underwent DNA amplification and hybridization with
primers for different viruses of the family of herpesviruses.
The data for the patients with atypical necrotizing retinopathies
were compared with those for the patients with ARN and pa-
tients with CMV retinitis.
Patients
Between 1990 and 1995, 32 patients presenting with necro-
tizing retinopathies of suspected viral origin were treated at the
Departments of Ophthalmology at the University of Hamburg
(Hamburg, Germany) and the University of Bern (Bern, Swit-
zerland) (table 1). Aqueous humor samples were collected from
these patients and from 30 healthy controls undergoing anterior
segment surgery. On the basis of clinical findings, ocular pa-
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Table 1. Diagnoses for 32 patients presenting with necrotizing reti-
nopathies.
Clinical diagnosis, history No. of patients
No. with history of
zoster dermatitis
Atypical retinopathy of suspected
viral origin 9 6
Remission after chemotherapy
for Hodgkin's disease
HIV infection 2 2
AIDS 6 3
Acute retinal necrosis syndrome 6 0
No previous disease 5 0
AIDS 0
Cytomegalovirus retinitis, AIDS 17 NA
NOTE. Additional information may be obtained from the text under the
heading of Patients. NA = data not available.
thologies fell into one of three categories: atypical retinopa-
thies, ARN, and CMV retinitis.
Atypical retinopathies of unknown origin. Atypical reti-
nopathy was diagnosed for nine patients since the clinical pic-
ture did not meet the criteria for either ARN or CMV retinitis
as defined by the American Uveitis Society [10, 20]. One of
these individuals had a history of Hodgkin's disease, which
was in remission following chemotherapy that had been admin-
istered 2 years before; zoster dermatitis was diagnosed 6
months prior to presentation for acute retinopathy. Two HIV-
positive patients had a history of zoster dermatitis that occurred.
3 and 6 months, respectively, prior to presentation for retinopa-
thy; in the latter case, viral encephalitis was diagnosed, and
CSF from this patient was also analyzed.
Of the six patients with AIDS, three had a history of zoster
dermatitis during the 8 months prior to presentation for retinop-
athy; one of these patients had had contralateral zoster kera-
touveitis 3 days before presentation for bilateral retinopathy.
The remaining three patients with AIDS presented without a
history of herpetic infection at any site. A subretinal fluid sam-
ple was obtained from one of these patients at the time of
retinal detachment surgery; this procedure was performed 9
days after the diagnosis of retinopathy at which time foscarnet
therapy was started.
ARN. ARN was diagnosed for five patients (two with bilat-
eral involvement) according to the criteria of the American
Uveitis Society [4, 10, 21]. In addition to aqueous humor sam-
ples, subretinal fluid specimens were also obtained from two
patients at the time of retinal detachment surgery. A sixth
patient with AIDS presented with bilateral ARN 2 months
after stabilization of CMV retinitis. This individual's CD4+
cell count spontaneously increased from 50 to 200/,uL before
the actual diagnosis of the disease.
CMV retinitis. On the basis of standard clinical criteria
[10, 20], CMV retinitis was diagnosed for 17 patients with
AIDS.
Controls. Controls included 30 healthy individuals who
had no signs of inflammatory ocular disease and who were
undergoing anterior segment surgery (mostly cataract opera-
tions).
Methods
Aqueous humor, subretinal fluid, and CSF samples were
centrifuged (13,000g for 10 minutes), and the sediments were
resuspended in 10 mM Tris buffer (pH 8.3) containing 0.1%
Tween 20 and 200 ktg of proteinase K/mL (Sigma, St. Louis).
These suspensions were then heated, initially to 56°C for 60
minutes and subsequently to 95°C for 10 minutes. Aliquots
were obtained on a routine basis for viral cultures by using
human embryonal lung fibroblasts (MRC-5 cells) as the host
cell; a culture was considered to be negative if no cytopathic
effect was observed after 20 days.
DNA amplification was performed according to conventional
protocols; the primers were based on previously reported se-
quences of the glycoprotein D gene [22] and the thymidine
kinase gene [23] of herpes simplex virus type 1 (HSV-1) as
well as those of main immediate early genes of varicella-zoster
virus (VZV) Mal M region [24]) and CMV (MIE 6/7 region
[25]). The amplification mix (final volume, 50 p,L) contained
5µL of resuspended sample pellet or supernatant, 40 pM
primer, 200 desoxynucleoside triphosphates, 10 mM Tris
(pH 8.3), 50 mM KC1, 2 mM MgCl 2 , 0.02% gelatin, and 1 U
of Thermus brockianus DNA polymerase (Finnzymes, Espoo,
Finland).
After initial DNA denaturation at 95°C for 5 minutes, 35
amplification cycles were performed; each cycle consisted of
denaturation at 95°C for 30 seconds, primer annealing at 60°C
(HSV-1) or 58°C (VZV and CMV) for 30 seconds, and frag-
ment elongation at 72°C for 90 seconds. Final elongation was
then done at 72°C for 10 minutes. PCR products were separated
on 3% agarose gels, and after the gels were stained with 0.03%
ethidium bromide, bands were visualized by scanning at
312 nm.
DNA was then transferred to nylon membranes (Hybond-
N±, Amersham, Arlington Heights, IL) and hybridized (buffer
composition, 5 X saline sodium citrate, 50% formamide, 0.5%
N-lauroylsarkosin, 0.02% SDS, and 2% blocking reagent
[Boehringer Mannheim, Mannheim, Germany]) with use of
oligonucleotides randomly labeled with digoxigenin and the
chemoluminescence detection system outlined by the manufac-
turer (Boehringer Mannheim).
All buffer solutions used in this study were included as
negative controls; internal positive controls included lysates of
infected MRC-5 cell cultures and aqueous humor samples
spiked with small amounts of HSV-1, VZV, and CMV.
Results
Each of the nine patients with necrotizing herpetic retinopa-
thies and the six patients with ARN had serum antibodies to
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VZV. In three of the patients with ARN, the titers of VZV in
both aqueous and serum samples were sufficiently high as to
permit an unequivocal assignment of etiology (data not pre-
sented), but none of the MRC-5 cell cultures of the aqueous
humor samples yielded viral growth.
Sensitivity of PCR analysis and Southern blotting. PCR
analysis of HSV-1 glycoprotein D revealed 10 -3 pfu per sample
after 35 DNA amplification cycles and 2 X 10' pfu after
Southern blot hybridization. After Southern blot hybridization,
1.5 pg of VZV DNA per sample of cell culture supernatants
was detected. After amplification, <10' pfu of CMV DNA
per sample was disclosed. Spiking with small amounts of viral
DNA did not result in significant inhibition of amplification in
aqueous humor samples, but amplification in subretinal fluid
samples was somewhat inhibited after spiking.
Both proteinase K—digested sediments and supernatants
from all aqueous humor samples were tested; viral DNA was
not detected exclusively in the supernatant in any instance, but
in one-third of the positive sediments, DNA was not amplified
from the corresponding supernatant. The results of DNA detec-
tion in aqueous humor samples are summarized in table 2.
Atypical retinopathies of suspected viral origin. VZV
DNA was amplified in aqueous humor samples from seven of
the nine patients, including the patient with Hodgkin's disease;
two samples contained no target DNA after repeated testing.
Neither HSV-1 DNA nor CMV DNA was found in any of the
samples from these individuals. VZV DNA was detected in
the CSF sample from the patient with viral encephalitis; this
result was in accordance with the result for the aqueous humor
sample.
ARN. VZV DNA was found in aqueous humor samples
from four of six patients with ARN; in one sample, no viral
DNA was detected (table 2) (figure 1). Strong signals of ampli-
fication for both HSV-1 DNA and CMV DNA were found in
the aqueous humor samples from the patient with AIDS and
bilateral ARN. VZV DNA was detected in one of the two
subretinal fluid samples from two otherwise healthy patients
with secondary retinal detachment; the samples were obtained
at the time of surgery, which was performed 8-15 days after
the onset of therapy. During the subsequent symptom-free fol-
low-up (3 —24 months), no viral DNA was detected in any of
seven aqueous humor samples from the patient for whom VZV
DNA was found in the aqueous humor sample and the subreti-
nal fluid sample obtained at the time of retinal detachment
surgery.
CMV retinitis. CMV DNA was detected in 14 of the 17
aqueous humor samples from patients with AIDS and CMV
retinitis. DNA from the thymidine kinase gene, but not from
the glycoprotein D gene, of HSV-1 was amplified to a lesser
degree in two of the sampleg from CMV-positive individuals,
but in no instance was VZV DNA found (table 2).
Healthy controls. No viral DNA was detected in any of
the aqueous humor samples from healthy controls. The likeli-
hood of finding VZV DNA in samples from patients with
atypical retinopathies of suspected viral origin is significantly
greater than that in samples from patients with CMV retinitis
or healthy controls (P < .0001; Fisher's exact test) but
not than that in samples from patients with ARN (P = 1.0;
Fisher's exact test).
Discussion
The results of the current investigation reveal a close correla-
tion between the manifestation of atypical necrotizing retinopa-
thies and the presence of VZV DNA, a finding that has not been
previously reported. However, living virus was not detected in
any of the aqueous humor samples from our patients. With
respect to the clinical picture itself, the association between
acute necrotizing retinopathies and Herpesviridae [3, 26] has
been long debated [27]. It was not until 1976 that the first
electron microscopic studies identified HSV [28] and VZV [29]
as possible etiologic agents. Using immunocytochemistry and
electron microscopy, Culbertson et al. [21] demonstrated the
presence of viral particles in the retina of eyes enucleated from
patients with ARN, and later they [11] were able to isolate
VZV in cell cultures of one of two enucleated eyes. However,
Table 2. Detection of viral DNA in aqueous humor samples from patients with necrotizing retinopa-
thies and healthy controls.
No. of samples
No. of patients Clinical diagnosis No DNA HSV-1 DNA VZV DNA CMV DNA
9 Atypical retinopathies of
suspected viral origin
2 0 7 0
6 Acute retinal necrosis syndrome 1 1 4 1
17 CMV retinitis 3 2* 0 14
30 Healthy 30 0 0 0
NOTE. CMV = cytomegalovirus; HSV-1 	 herpes simplex virus type 1; VZV varicella-zoster virus.
* DNA from the thymidine kinase gene, but not from the glycOprotein D gene, of HSV-1 was detectable at low
copy numbers (only after DNA hybridization) in two of the CMV-positive aqueous humor samples.
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Figure 1. A. Varicella-zoster virus (VZV) DNA (126 by in length) detected in aqueous humor samples from patients with necrotizing
retinopathies; band patterns after 35 amplification cycles. PCR products were separated on a 3% agarose gel after staining with 0.01% ethidium
bromide (left) and after Southern blot and DNA hybridization with use of a digoxigenin-labeled probe (right). Lanes 1 and 13, molecular
weight markers; lanes 2-5, patient with acute retinal necrosis syndrome (2, aqueous humor sediment; 3, aqueous humor supernatant; 4,
peripheral blood monocytes [PBMC]; 5, serum); lanes 6-8 and 21, aqueous humor samples from patients with AIDS and cytomegalovirus
retinitis; lanes 9-12 and 14-17, patient with zoster keratouveitis (9-12, aqueous humor samples at diagnosis [9 and /0] and 2 weeks later
[11 and 12]; 14-17, corneal tissue samples); lanes 18-20 and 22, immunodompetent, otherwise healthy patient with retinal vasculitis of
possible viral origin (18, aqueous humor sediment; 19, aqueous humor supernatant; 20, PBMC; 22, serum); lane 23, buffer control; and lane
24, positive control (supernatant from VZV-infected cell culture). B. Chemoluminescence detection of bound probe after Southern blot and
DNA hybridization from the gel in A. kb = kilobases.
since that time, only nine cases of viral origin have been proven
by cultures of aqueous and vitreous samples collected at the
time of diagnosis, and three of these cases occurred in patients
with AIDS [30, 31].
Recently, the viral etiology in culture-negative cases of ARN
was confirmed by electron microscopic demonstration of viral
particles, antigen immunofluorescence testing, and/or immuno-
cytology; infection was found to be attributable to VZV in 80%
of these cases [20, 30, 32-34]. These data correspond well
with our findings with respect to the presence of VZV DNA
in aqueous humor samples from patients with ARN; this agree-
ment is encouraging since it indicates that amplification of
DNA in aqueous humor samples represents an appropriate
method for detecting the causative agent of acute retinopathies.
Moreover, the fact that aqueous humor samples are suitable
for such purposes obviates the necessity of obtaining vitreous
or subretinal fluid samples. Indeed, these latter specimens may
represent inferior sources of material for DNA amplification
from the point of view of sensitivity (and hence of detection
limits) since when these samples were spiked with small
amounts of target DNA the amplification was somewhat inhib-
ited in comparison with the amplification in aqueous humor
samples.
The association found between VZV and atypical necrotizing
retinopathies is comparable with those existing between VZV
and ARN [19] and between CMV and retinitis [24, 25, 35].
No VZV DNA was detected in 17 aqueous humor samples
from patients with AIDS and CMV retinitis, but evidence for
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a dual infection with HSV-1 and CMV was found in two of
the patients with CMV retinitis and in one patient with ARN;
such an association also has been reported in other studies [16,
24, 36].
At present, PCR technology is not generally accepted as a
standard laboratory procedure, albeit it has been employed for
the diagnosis of well-defined necrotizing retinopathies (such
as ARN and CMV retinitis) as well as for the detection of
DNA from HSV-1 [12, 19, 37], HSV type 2 [38], VZV [19,
31, 39], CMV [24, 25, 35], Epstein-Barr virus [40], and human
herpesvirus 6 [36]. Data derived by such means should there-
fore always be confirmed by established methods. PCR findings
were confirmed by serological investigations of paired samples
in 50% of our cases of ARN [16], but such analysis was not
undertaken for individuals with atypical necrotizing retino-
pathies.
In summary, our data, taken together with the findings re-
ported in the literature, indicate that early, reliable identification
of the pathogenic agent may be ascertained by PCR analysis
in 70%-80% of cases of necrotizing retinopathies of any form
at the time of diagnosis, irrespective of the causative agent.
Atypical necrotizing retinopathies are most likely caused by
an infection of the retina with VZV.
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